{"entity":{"type":"insider","cik":"0001799325","url":"/insider/0001799325","json_url":"/insider/0001799325.json","name":"Marshall Randall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":16,"first":"2020-07-14","last":"2020-09-15","span_basis":"filed_date"},"name_variants":[{"name":"Marshall Randall","source":"filing","n_filings":16,"first_seen":"2020-07-14","last_seen":"2020-09-15"}],"transactions":[{"id":3232025,"accession":"0001179110-20-009785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009785","line_url":"/filing/0001179110-20-009785#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":19.26,"price_display":"19.26","price_state":"stated","total_value":40060.8,"total_display":"40,060.80","shares_owned_after":586074.0,"shares_owned_after_display":"586,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-15","scope":"insider"},{"id":3232020,"accession":"0001179110-20-009785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009785","line_url":"/filing/0001179110-20-009785#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":474.0,"shares_display":"474","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":9480.0,"total_display":"9,480.00","shares_owned_after":585600.0,"shares_owned_after_display":"585,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-15","scope":"insider"},{"id":2151022,"accession":"0001179110-20-009717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009717","line_url":"/filing/0001179110-20-009717#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4302.0,"total_display":"4,302.00","shares_owned_after":588154.0,"shares_owned_after_display":"588,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider"},{"id":2527655,"accession":"0001179110-20-009662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-009662","line_url":"/filing/0001179110-20-009662#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5309.0,"shares_display":"5,309","price_per_share":18.1,"price_display":"18.10","price_state":"stated","total_value":96092.9,"total_display":"96,092.90","shares_owned_after":593306.0,"shares_owned_after_display":"593,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"},{"id":2527653,"accession":"0001179110-20-009662","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009662","line_url":"/filing/0001179110-20-009662#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4913.0,"shares_display":"4,913","price_per_share":19.27,"price_display":"19.27","price_state":"stated","total_value":94673.51,"total_display":"94,673.51","shares_owned_after":588393.0,"shares_owned_after_display":"588,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"},{"id":2527649,"accession":"0001179110-20-009662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009662","line_url":"/filing/0001179110-20-009662#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3108.0,"shares_display":"3,108","price_per_share":18.94,"price_display":"18.94","price_state":"stated","total_value":58865.52,"total_display":"58,865.52","shares_owned_after":598615.0,"shares_owned_after_display":"598,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":3145407,"accession":"0001179110-20-009590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009590","line_url":"/filing/0001179110-20-009590#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":20.19,"price_display":"20.19","price_state":"stated","total_value":1049.88,"total_display":"1,049.88","shares_owned_after":601723.0,"shares_owned_after_display":"601,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-04","scope":"insider"},{"id":3145403,"accession":"0001179110-20-009590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009590","line_url":"/filing/0001179110-20-009590#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":20.68,"price_display":"20.68","price_state":"stated","total_value":4280.76,"total_display":"4,280.76","shares_owned_after":601775.0,"shares_owned_after_display":"601,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-04","scope":"insider"},{"id":2973690,"accession":"0001179110-20-009466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009466","line_url":"/filing/0001179110-20-009466#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":771.0,"shares_display":"771","price_per_share":22.09,"price_display":"22.09","price_state":"stated","total_value":17031.39,"total_display":"17,031.39","shares_owned_after":601982.0,"shares_owned_after_display":"601,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":2184563,"accession":"0001179110-20-009407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009407","line_url":"/filing/0001179110-20-009407#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":616.0,"shares_display":"616","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":13779.92,"total_display":"13,779.92","shares_owned_after":602753.0,"shares_owned_after_display":"602,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-27","filed_date":"2020-08-28","scope":"insider"},{"id":2184558,"accession":"0001179110-20-009407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009407","line_url":"/filing/0001179110-20-009407#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1418.0,"shares_display":"1,418","price_per_share":22.4,"price_display":"22.40","price_state":"stated","total_value":31763.2,"total_display":"31,763.20","shares_owned_after":603369.0,"shares_owned_after_display":"603,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-28","scope":"insider"},{"id":2431952,"accession":"0001179110-20-009359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009359","line_url":"/filing/0001179110-20-009359#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2461.0,"shares_display":"2,461","price_per_share":22.73,"price_display":"22.73","price_state":"stated","total_value":55938.53,"total_display":"55,938.53","shares_owned_after":604787.0,"shares_owned_after_display":"604,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"},{"id":2431945,"accession":"0001179110-20-009359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009359","line_url":"/filing/0001179110-20-009359#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":23.16,"price_display":"23.16","price_state":"stated","total_value":22557.84,"total_display":"22,557.84","shares_owned_after":607248.0,"shares_owned_after_display":"607,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-26","scope":"insider"},{"id":3231956,"accession":"0001179110-20-009241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009241","line_url":"/filing/0001179110-20-009241#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":24.183,"price_display":"24.18","price_state":"stated","total_value":12333.33,"total_display":"12,333.33","shares_owned_after":608222.0,"shares_owned_after_display":"608,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-24","scope":"insider"},{"id":3293584,"accession":"0001179110-20-009191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009191","line_url":"/filing/0001179110-20-009191#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":25.19,"price_display":"25.19","price_state":"stated","total_value":5038.0,"total_display":"5,038.00","shares_owned_after":608732.0,"shares_owned_after_display":"608,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2114388,"accession":"0001179110-20-009153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009153","line_url":"/filing/0001179110-20-009153#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1548.0,"shares_display":"1,548","price_per_share":25.11,"price_display":"25.11","price_state":"stated","total_value":38870.28,"total_display":"38,870.28","shares_owned_after":608932.0,"shares_owned_after_display":"608,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2114386,"accession":"0001179110-20-009153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009153","line_url":"/filing/0001179110-20-009153#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":25.09,"price_display":"25.09","price_state":"stated","total_value":17563.0,"total_display":"17,563.00","shares_owned_after":610480.0,"shares_owned_after_display":"610,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-18","scope":"insider"},{"id":2575297,"accession":"0001179110-20-008623","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-008623","line_url":"/filing/0001179110-20-008623#line-4","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1317.0,"shares_display":"1,317","price_per_share":26.14,"price_display":"26.14","price_state":"stated","total_value":34426.38,"total_display":"34,426.38","shares_owned_after":611180.0,"shares_owned_after_display":"611,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-30","filed_date":"2020-07-31","scope":"insider"},{"id":2575293,"accession":"0001179110-20-008623","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008623","line_url":"/filing/0001179110-20-008623#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1816.0,"shares_display":"1,816","price_per_share":26.03,"price_display":"26.03","price_state":"stated","total_value":47270.48,"total_display":"47,270.48","shares_owned_after":613197.0,"shares_owned_after_display":"613,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-31","scope":"insider"},{"id":2575288,"accession":"0001179110-20-008623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008623","line_url":"/filing/0001179110-20-008623#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":27.28,"price_display":"27.28","price_state":"stated","total_value":16368.0,"total_display":"16,368.00","shares_owned_after":612597.0,"shares_owned_after_display":"612,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-31","scope":"insider"},{"id":2575283,"accession":"0001179110-20-008623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008623","line_url":"/filing/0001179110-20-008623#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":28.45,"price_display":"28.45","price_state":"stated","total_value":2845.0,"total_display":"2,845.00","shares_owned_after":612497.0,"shares_owned_after_display":"612,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-31","scope":"insider"},{"id":2150894,"accession":"0001179110-20-008539","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-8","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14243.0,"shares_display":"14,243","price_per_share":30.42,"price_display":"30.42","price_state":"stated","total_value":433272.06,"total_display":"433,272.06","shares_owned_after":621956.0,"shares_owned_after_display":"621,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150892,"accession":"0001179110-20-008539","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-7","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3493.0,"shares_display":"3,493","price_per_share":31.53,"price_display":"31.53","price_state":"stated","total_value":110134.29,"total_display":"110,134.29","shares_owned_after":618463.0,"shares_owned_after_display":"618,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150890,"accession":"0001179110-20-008539","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-6","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":26.85,"price_display":"26.85","price_state":"stated","total_value":69810.0,"total_display":"69,810.00","shares_owned_after":638010.0,"shares_owned_after_display":"638,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150888,"accession":"0001179110-20-008539","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-5","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1811.0,"shares_display":"1,811","price_per_share":28.63,"price_display":"28.63","price_state":"stated","total_value":51848.93,"total_display":"51,848.93","shares_owned_after":636199.0,"shares_owned_after_display":"636,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150887,"accession":"0001179110-20-008539","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-4","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1650.0,"shares_display":"1,650","price_per_share":33.79,"price_display":"33.79","price_state":"stated","total_value":55753.5,"total_display":"55,753.50","shares_owned_after":615613.0,"shares_owned_after_display":"615,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150885,"accession":"0001179110-20-008539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":33.09,"price_display":"33.09","price_state":"stated","total_value":39708.0,"total_display":"39,708.00","shares_owned_after":617263.0,"shares_owned_after_display":"617,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150882,"accession":"0001179110-20-008539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":35.45,"price_display":"35.45","price_state":"stated","total_value":21270.0,"total_display":"21,270.00","shares_owned_after":615013.0,"shares_owned_after_display":"615,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"},{"id":2150879,"accession":"0001179110-20-008539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008539","line_url":"/filing/0001179110-20-008539#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":338.0,"shares_display":"338","price_per_share":26.08,"price_display":"26.08","price_state":"stated","total_value":8815.04,"total_display":"8,815.04","shares_owned_after":640610.0,"shares_owned_after_display":"640,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-29","scope":"insider"},{"id":2411175,"accession":"0001179110-20-008490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008490","line_url":"/filing/0001179110-20-008490#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","shares_owned_after":640948.0,"shares_owned_after_display":"640,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-24","filed_date":"2020-07-27","scope":"insider"},{"id":2411171,"accession":"0001179110-20-008490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008490","line_url":"/filing/0001179110-20-008490#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":26.58,"price_display":"26.58","price_state":"stated","total_value":51831.0,"total_display":"51,831.00","shares_owned_after":641341.0,"shares_owned_after_display":"641,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-23","filed_date":"2020-07-27","scope":"insider"},{"id":2411163,"accession":"0001179110-20-008490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008490","line_url":"/filing/0001179110-20-008490#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93.0,"shares_display":"93","price_per_share":27.29,"price_display":"27.29","price_state":"stated","total_value":2537.97,"total_display":"2,537.97","shares_owned_after":641248.0,"shares_owned_after_display":"641,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-23","filed_date":"2020-07-27","scope":"insider"},{"id":2064821,"accession":"0001179110-20-008426","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008426","line_url":"/filing/0001179110-20-008426#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297.0,"shares_display":"1,297","price_per_share":26.69,"price_display":"26.69","price_state":"stated","total_value":34616.93,"total_display":"34,616.93","shares_owned_after":643366.0,"shares_owned_after_display":"643,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-23","scope":"insider"},{"id":2064819,"accession":"0001179110-20-008426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008426","line_url":"/filing/0001179110-20-008426#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":27.445,"price_display":"27.44","price_state":"stated","total_value":2058.375,"total_display":"2,058.38","shares_owned_after":643291.0,"shares_owned_after_display":"643,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-23","scope":"insider"},{"id":2064817,"accession":"0001179110-20-008426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008426","line_url":"/filing/0001179110-20-008426#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":26.56,"price_display":"26.56","price_state":"stated","total_value":5922.88,"total_display":"5,922.88","shares_owned_after":644663.0,"shares_owned_after_display":"644,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-23","scope":"insider"},{"id":3053955,"accession":"0001179110-20-008399","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-008399","line_url":"/filing/0001179110-20-008399#line-3","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":26.7,"price_display":"26.70","price_state":"stated","total_value":60261.9,"total_display":"60,261.90","shares_owned_after":645358.0,"shares_owned_after_display":"645,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider"},{"id":3053947,"accession":"0001179110-20-008399","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008399","line_url":"/filing/0001179110-20-008399#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":27.68,"price_display":"27.68","price_state":"stated","total_value":13064.96,"total_display":"13,064.96","shares_owned_after":644886.0,"shares_owned_after_display":"644,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider"},{"id":3053939,"accession":"0001179110-20-008399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008399","line_url":"/filing/0001179110-20-008399#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1601.0,"shares_display":"1,601","price_per_share":26.66,"price_display":"26.66","price_state":"stated","total_value":42682.66,"total_display":"42,682.66","shares_owned_after":647615.0,"shares_owned_after_display":"647,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-07-21","scope":"insider"},{"id":3336975,"accession":"0001179110-20-008254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008254","line_url":"/filing/0001179110-20-008254#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":27.13,"price_display":"27.13","price_state":"stated","total_value":58193.85,"total_display":"58,193.85","shares_owned_after":649216.0,"shares_owned_after_display":"649,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-14","scope":"insider"},{"id":3336973,"accession":"0001179110-20-008254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-008254","line_url":"/filing/0001179110-20-008254#line-1","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"Protara Therapeutics, Inc.","issuer_ticker":"TARA","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001799325","owner_name":"Marshall Randall","owner_url":"/insider/0001799325","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2659.0,"shares_display":"2,659","price_per_share":27.41,"price_display":"27.41","price_state":"stated","total_value":72883.19,"total_display":"72,883.19","shares_owned_after":651361.0,"shares_owned_after_display":"651,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"Protara Therapeutics, Inc.","url":"/issuer/0001359931","role":"Ten percent owner, Other","n_filings":16,"first_seen":"2020-07-14","last_seen":"2020-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799325","retrieved_at":"2026-08-21T05:52:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}